Search Results

Showing results 181-191 of 210 for 'Community'


  • 2018-year-at-a-glance.jpg
    Weizmann Institute 2018 Year at a Glance

    Four of the Institute’s newest recruits—Drs. Amir Abboud, Yaron Antebi, Noam Tal Hod, and Sergey Semenov—kick off this review of the Weizmann Institute’s phenomenal progress in 2018. They lead us into the David Lopatie Conference Centre, where we’re introduced to other new faculty members who came aboard this year: Drs. Moran Shalev-Benami, Naama Kanarek, Filipe Natalio, Serge Rosenblum, Sivan Refaely Abramson, Giora Alexandron, and Yael Kiro.

    /news-media/video-gallery/weizmann-institute-2018-year-at-a-glance
  • Wallpaper.jpg
  • Henry Fenichel with Weizmann.jpg
    Dr. Henry Fenichel: On Survival, Science, and Fate

    At the age of eight, Henry Fenichel, a child survivor of the Holocaust, met Dr. Chaim Weizmann. The young boy would go on to become an accomplished physicist, a visiting scientist at the Weizmann Institute, and the co-author of a biography of the Institute's first scientific director.

    /news-media/feature-stories/dr-henry-fenichel-on-survival-science-and-fate
  • 2019-01-ACWIS-eNews-web-ver (1).jpg
  • chicago-tribune.jpg
  • Czech_students.jpg
    Israeli and Czech Scientists Join Forces in Advancing Drug Discovery

    To expand the ties between the Israeli and Czech scientific communities, their countries are developing new forms of collaboration among talented young scientists. One such project is the “Joint Prague-Weizmann Winter School on Drug Discovery.” This intensive week of professional lectures is attended by more than 120 scientists and students from around the world. The project provides a unique opportunity for young Israeli and Czech researchers to meet and discuss the latest trends and challenges in drug development, as well as to meet with world leaders in academia and experts from such multinational pharmaceutical giants as MSD, Roche, and Astra Zeneca.

    /news-media/news-releases/israeli-and-czech-scientists-join-forces-in-advancing-drug-discovery
  • WEIZMANN-IN-FOCUS-PLAY-SCREEN-weizmann-usa.jpg
    Weizmann in Focus, Episode 1: How AI is Improving Heart Health

    We invite you to watch <em>Weizmann in Focus</em>, a new video series featuring American Committee CEO Dave Doneson. In this inaugural episode, Dave introduces one of the Weizmann Institute’s newest initiatives: the Artificial Intelligence Center for Scientific Exploration. He then explains how Prof. Yaron Lipman’s recent AI breakthrough is improving health care for heart patients.

    /news-media/video-gallery/weizmann-in-focus-episode-1-how-ai-is-improving-heart-health
  • 24 Hours.JPG
    24 Hours of the Weizmann Institute of Science

    Catch a glimpse of one day in the life of the Weizmann Institute, where scientists and graduate students collaborate in a unique culture of curiosity. Meet some of the passionate researchers on campus who question, explore, and discover.

    /news-media/video-gallery/24-hours-of-the-weizmann-institute-of-science
  • blavatnikawards.jpg
  • weizmann-house.jpg (1)
    Between Patroness and Architect: Vera Weizmann’s Part in the Design of Weizmann House in Rehovot

    “You’ve built me a modern, beautiful house, but I cannot live with your design... I must remind you that it is I who have to live in the house, not you”. Vera Weizmann, in a letter to architect Erich Mendelsohn. The patron/artist relationship touches on one of the most complex issues in the architectural profession. In contrast to any other art work where the creative aspirations of the artist constitute the main functional medium, architecture focuses on the client’s ambition, particularly in relation to private houses, where a list of requests express his taste, dreams, social status and lifestyle.

    /news-media/in-the-news/between-patroness-and-architect